These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1711914)

  • 1. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.
    Chen J; Paredes W; Van Praag HM; Lowinson JH; Gardner EL
    Synapse; 1992 Mar; 10(3):264-6. PubMed ID: 1557698
    [No Abstract]   [Full Text] [Related]  

  • 3. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.
    McNeish CS; Svingos AL; Hitzemann R; Strecker RE
    Pharmacol Biochem Behav; 1993 Aug; 45(4):759-63. PubMed ID: 8415815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.
    De Deurwaerdère P; Stinus L; Spampinato U
    J Neurosci; 1998 Aug; 18(16):6528-38. PubMed ID: 9698340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
    Ashby CR; Minabe Y; Edwards E; Wang RY
    Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.
    Invernizzi R; Pozzi L; Samanin R
    Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens.
    Yoshimoto K; McBride WJ; Lumeng L; Li TK
    Alcohol; 1992; 9(1):17-22. PubMed ID: 1370758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT3 receptor antagonist ondansetron does not alter effects of amphetamine on DA metabolism.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B; Virtanen R
    Neuroreport; 1990 Oct; 1(2):126-8. PubMed ID: 2151795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens.
    Campbell AD; McBride WJ
    Pharmacol Biochem Behav; 1995 Aug; 51(4):835-42. PubMed ID: 7675866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen.
    Chen J; Paredes W; van Praag HM; Gardner EL
    Brain Res; 1992 Jun; 582(1):173-9. PubMed ID: 1379872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
    Middlefell VC; Price TL
    Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron.
    Toral J; Hu W; Critchett D; Solomon AJ; Barrett JE; Sokol PT; Ziai MR
    J Pharm Pharmacol; 1995 Jul; 47(7):618-22. PubMed ID: 8568632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 20. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.